101 related articles for article (PubMed ID: 101431)
1. [Conservative treatment of peripheral arterial occlusive diseases].
Hoffmann J
Fortschr Med; 1978 Sep; 96(34):1735-8. PubMed ID: 101431
[TBL] [Abstract][Full Text] [Related]
2. [Clinical treatment of peripheral arterial occlusive diseases].
Schulte B
Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
Wampola H
Fortschr Med; 1977 May; 95(18):1240,1242-5. PubMed ID: 405291
[TBL] [Abstract][Full Text] [Related]
4. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.
Milio G; Cospite V; Cospite M
Minerva Cardioangiol; 2003 Jun; 51(3):311-6. PubMed ID: 12867883
[TBL] [Abstract][Full Text] [Related]
5. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
Brüning G
Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
[No Abstract] [Full Text] [Related]
6. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
7. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Heidrich H
Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
[No Abstract] [Full Text] [Related]
8. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.
Schweizer J; Hautmann C
Arzneimittelforschung; 1999 Nov; 49(11):900-4. PubMed ID: 10604042
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
König FK
Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
[No Abstract] [Full Text] [Related]
10. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
Paoletti V; Mammarella A; Alessandrini A; Barlattani M
Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
[No Abstract] [Full Text] [Related]
11. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
Trübestein G; Trübestein R; Ludwig M
Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
[TBL] [Abstract][Full Text] [Related]
12. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
Schuster CJ; von Ungern-Sternberg AF
ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527
[No Abstract] [Full Text] [Related]
13. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
Seboldt H
Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
[TBL] [Abstract][Full Text] [Related]
14. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
Rossini A; Tascino C; Costa F
Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
Traumann KJ
Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
[TBL] [Abstract][Full Text] [Related]
16. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
Masini G
Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
[No Abstract] [Full Text] [Related]
17. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
[TBL] [Abstract][Full Text] [Related]
18. Intravenous prostavasin--therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study.
Heidrich H; Meuche C; Ranft J; Rummel S; Peters A
Prog Clin Biol Res; 1989; 301():411-6. PubMed ID: 2678131
[No Abstract] [Full Text] [Related]
19. [Drug therapy of arterial diseases. A study with Trental 400].
Tannenberg G
Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
[TBL] [Abstract][Full Text] [Related]
20. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
Bauer U
Arzneimittelforschung; 1984; 34(6):716-20. PubMed ID: 6386008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
